Research Highlights

MTN is excited to announce that MTN-033 has completed enrollment.


Microbicide Trials Network Research Prominent at 2018 HIV R4P.


MTN is excited to announce the launch of MTN-037.


MTN-033 is launched.


MTN presented preliminary results from the HOPE study (MTN-025) at CROI 2018.


The first-ever study of dapivirine gel as a rectal microbicide has begun.


Study on a vaginal ring for both HIV and pregnancy prevention completed.

Source URL: